This is a hugely undervalued company. Most on this forum have...

This is a hugely undervalued company. Most on this forum have lost heavily. I myself have to, but my smsf was lucky to pick up a few at $1 so that's doing ok. Without anymore dilution this stock has the potential to be a $50-$100 stock. Their lead product Iluvien™, has a huge potential market. I don't see any reason why this won't get FDA approval in early/mid 2010. Buy on the dips and hold for 12 months :) Call me a ramper, but i'm just calling it as i see it. p.s. their new website looks a lot better than the old one. http://www.psivida.com/